SENATE RESOLUTION NO. 515
         WHEREAS, Focal segmental glomerulosclerosis is a rare
  condition that frequently leads to chronic kidney disease and
  kidney failure; and
         WHEREAS, FSGS causes scarring in the glomeruli, the small
  filters in the kidney that remove waste from the blood; it often
  progresses rapidly to kidney failure, with half of FSGS patients
  requiring dialysis or a kidney transplant within 5 to 10 years of
  diagnosis; and
         WHEREAS, According to the RaDaR Database, patients with
  rare kidney conditions such as FSGS make up just 5 to 10 percent
  of chronic kidney disease patients but account for approximately
  30 percent of kidney failure; and
         WHEREAS, Commonly diagnosed in adulthood and most
  prevalent in individuals over age 45, FSGS occurs in certain
  populations, including those with African ancestry, at much
  higher rates than in the general population; many patients face
  delays in being diagnosed with FSGS, due to the difficulty of
  rare disease diagnosis, which takes an average of five to seven
  years, and the limited availability of specialized care for rare
  kidney diseases; moreover, some FSGS patients experience delays
  in accessing kidney transplants; and
         WHEREAS, FSGS imposes a heavy burden on the U.S. health
  care system; a 2019 study estimated that the disease costs public
  and private health insurers about $2 billion annually; and
         WHEREAS, There is new hope for patients with FSGS, with
  clinical trials underway for products that may delay the
  progression of FSGS and the onset of kidney disease; patients,
  families, health care providers, researchers, and advocacy
  organizations like NephCure and the Texas Kidney Foundation are
  working tirelessly to promote early detection and to develop
  innovative therapies for FSGS and other rare kidney diseases; a
  patient-led and community-based organization, the Texas Kidney
  Foundation conducts comprehensive kidney screenings as well as
  genetic testing specifically focused on identifying rare kidney
  diseases, including more than 300 rare and chronic kidney
  conditions; through these innovative efforts, the foundation plays
  a vital and unique role in advancing early diagnosis, empowering
  patients through education and awareness, and expanding statewide
  access to personalized and proactive treatment options; and
         WHEREAS, FSGS Awareness Day serves as an important means to
  inform the public and the medical community about this deadly
  disease, to provide support and inspiration to FSGS patients and
  their families, and to promote better access to diagnosis and
  treatment; now, therefore, be it
         RESOLVED, That the Senate of the State of Texas, 89th
  Legislature, hereby recognize June 10, 2025, as FSGS Awareness Day.
 
  Campbell
   
   
    ________________________________ 
        President of the Senate
     
        I hereby certify that the
    above Resolution was adopted by
    the Senate on May 14, 2025.
   
   
    ________________________________ 
        Secretary of the Senate
   
   
    ________________________________ 
         Member, Texas Senate